malondialdehyde has been researched along with dihydropyridines in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 11 (44.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, DQ; Pang, ZQ; Sheng, BH; Zhao, DH | 1 |
| Liu, DQ; Sheng, BH; Zhao, DH | 1 |
| Ebersole, BJ; Molinoff, PB | 1 |
| Brunk, UT; Yin, DZ | 1 |
| Costantini, C; d'Ischia, M; Prota, G | 1 |
| Bailey, AJ; Murray, M; Slatter, DA | 1 |
| Armas-Hernández, MJ; Armas-Padilla, MC; Carvajal, AR; Castillo-Moreno, A; Hernández-Hernández, R; Pacheco, B; Velasco, M | 1 |
| Ishii, T; Itakura, K; Kobayashi, M; Kumazawa, S; Nakayama, T; Osawa, T; Sakai, K; Shibata, N; Uchida, K; Yamada, S | 1 |
| Li, ZC; Mei, QB; Song, JC; Zhang, FQ; Zhao, DH | 1 |
| Acuña-Castroviejo, D; Escames, G; González, L; Khaldy, H; León, J | 1 |
| Allanore, Y; Borderie, D; Ekindjian, OG; Kahan, A; Lemaréchal, H | 1 |
| Campagnola, M; Cominacini, L; Cristofori, P; Crivellente, F; Faustinelli, I; Garbin, U; Pasini, AF; Rigoni, A; Tosetti, M; Turton, J | 1 |
| Duryee, MJ; Freeman, TL; Hamel, FG; Haver, A; Klassen, LW; Rennard, SI; Thiele, GM; Tuma, DJ; White, RL | 1 |
| Li, G; Li, L; Sheng, S; Yin, D | 1 |
| Uchida, K | 1 |
| Catena, C; Donnini, D; Milocco, C; Moretti, M; Sechi, LA; Soardo, G | 1 |
| Anazawa, T; Fuji, T; Furuya, S; Hirayama, A; Iida, K; Kawamata, H; Kumabe, T; Matsumoto, M; Nagao, K; Sato, Y; Takahashi, H; Tani, S | 1 |
| Anderson, DR; Duryee, MJ; Garvin, RP; Hunter, CD; Klassen, LW; Schaffert, CS; Thiele, GM; Tuma, DJ | 1 |
| Bermudez, Y; Hurst, CA; Park, SL; Stratton, SP; Uchida, K; Williams, JD; Wondrak, GT | 1 |
| Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Kumfu, S | 1 |
| Akhtar, M; Akhtar, MS; Ali, J; Haque, SE; Hassan, MQ; Najmi, AK | 1 |
| Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Jaiwongkam, T; Kerdphoo, S; Khamseekaew, J; Kumfu, S; Srichairatanakool, S; Wongjaikam, S | 1 |
| Arslan Nayki, U; Atakan Al, R; Balci, G; Cankaya, M; Suleyman, B; Suleyman, H; Unlubilgin, E | 1 |
| Ashraf, GM; Barreto, GE; Chavda, V; Patel, SS; Rajput, R | 1 |
| Altuner, D; Arslan, R; Bedir, F; Çoban, TA; Kocaturk, H; Suleyman, H; Turangezli, Ö | 1 |
1 review(s) available for malondialdehyde and dihydropyridines
| Article | Year |
|---|---|
Lipofuscin-like fluorophores originated from malondialdehyde.
Topics: Atherosclerosis; Dihydropyridines; Fluorescent Dyes; Humans; Immunohistochemistry; Lipid Peroxidation; Lipofuscin; Lipoproteins, LDL; Lysine; Malondialdehyde | 2006 |
3 trial(s) available for malondialdehyde and dihydropyridines
| Article | Year |
|---|---|
Effect of lacidipine and nifedipine GITS on platelet function in patients with essential hypertension.
Topics: Arachidonic Acid; Biomarkers; Blood Platelets; Blood Pressure; Calcium Channels; Dihydropyridines; Female; Heart Rate; Humans; Hypertension; Male; Malondialdehyde; Middle Aged; Nifedipine; Platelet Aggregation; Posture; Single-Blind Method | 2000 |
Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Cholesterol; Dihydropyridines; Female; Humans; Hypertension; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress | 2004 |
Acute and sustained effects of dihydropyridine-type calcium channel antagonists on oxidative stress in systemic sclerosis.
Topics: Adult; Aged; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Scleroderma, Systemic; Sulfhydryl Compounds; Time Factors | 2004 |
21 other study(ies) available for malondialdehyde and dihydropyridines
| Article | Year |
|---|---|
[Effects of furyl-dihydropyridines I on lipid peroxides of ischemic myocardium and ATPases activity of erythrocyte membranes in rats].
Topics: Animals; Aspartate Aminotransferases; Calcium Channel Blockers; Calcium-Transporting ATPases; Dihydropyridines; Erythrocyte Membrane; Fatty Acids, Nonesterified; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Rats; Sodium-Potassium-Exchanging ATPase | 1991 |
Prevention of global myocardial reperfusion injury on isolated rabbit hearts with furyl-dihydropyridines I.
Topics: Animals; Calcium; Calcium Channel Blockers; Creatine Kinase; Dihydropyridines; Hydroxybutyrate Dehydrogenase; In Vitro Techniques; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Rabbits; Sodium; Vascular Resistance | 1991 |
Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation.
Topics: Animals; Ascorbic Acid; Binding Sites; Brain; Calcium Channel Blockers; Cell Membrane; Culture Techniques; Dihydropyridines; Iron; Isradipine; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Microfluorometric and fluorometric lipofuscin spectral discrepancies: a concentration-dependent metachromatic effect?
Topics: Aging; Animals; Dihydropyridines; Evaluation Studies as Topic; Humans; Lipid Peroxidation; Lipofuscin; Malondialdehyde; Microscopy, Fluorescence; Schiff Bases; Spectrometry, Fluorescence | 1991 |
Lipofuscin-like pigments by autoxidation of polyunsaturated fatty acids in the presence of amine neurotransmitters: the role of malondialdehyde.
Topics: Arachidonic Acid; Biogenic Monoamines; Chromatography, High Pressure Liquid; Dihydropyridines; Fluorescent Dyes; Lipid Peroxidation; Lipofuscin; Malondialdehyde; Neurotransmitter Agents | 1996 |
Formation of a dihydropyridine derivative as a potential cross-link derived from malondialdehyde in physiological systems.
Topics: Cross-Linking Reagents; Dihydropyridines; Lysine; Malondialdehyde; Propylamines | 1998 |
Immunochemical detection of a lipofuscin-like fluorophore derived from malondialdehyde and lysine.
Topics: Animals; Antibodies, Monoclonal; Arteriosclerosis; Copper; Dihydropyridines; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fluorescent Dyes; Hemocyanins; Humans; Immunohistochemistry; Insulin; Lipid Peroxidation; Lipofuscin; Lipoproteins, LDL; Lysine; Malondialdehyde; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Serum Albumin, Bovine | 2001 |
Therapeutic effects of DCDDP, a calcium channel blocker, on chronic pulmonary hypertension in rat.
Topics: Animals; Calcium; Calcium Channel Blockers; Cell Division; Cells, Cultured; Chronic Disease; Dicarboxylic Acids; Dihydropyridines; Endothelins; Hemodynamics; Hypertension, Pulmonary; Male; Malondialdehyde; Monocrotaline; Muscle, Smooth, Vascular; Nitrendipine; Nitric Oxide; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Serotonin; Superoxide Dismutase; Vasoconstriction | 2002 |
Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation.
Topics: Animals; Antioxidants; Apolipoproteins E; Arteriosclerosis; Calcium Channel Blockers; Dihydropyridines; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Lipid Peroxidation; Lipoproteins, LDL; Malondialdehyde; Mice; Mice, Knockout; Random Allocation; Vitamin E | 2004 |
Aldehydes in cigarette smoke react with the lipid peroxidation product malonaldehyde to form fluorescent protein adducts on lysines.
Topics: Aldehydes; Chromatography, High Pressure Liquid; Dihydropyridines; Fluorescence; Lipid Peroxidation; Lysine; Malondialdehyde; Nicotiana; Proteins; Smoking; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Tobacco Smoke Pollution | 2005 |
Substantial reaction between histamine and malondialdehyde: a new observation of carbonyl stress.
Topics: Chromatography, High Pressure Liquid; Dihydropyridines; Histamine; Malondialdehyde; Neurotoxins; Nitrogen Compounds; Protein Carbonylation | 2005 |
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells.
Topics: Antihypertensive Agents; Captopril; Carbazoles; Carvedilol; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Endothelial Cells; Ethanol; Humans; Malondialdehyde; Nitric Oxide; Oxidative Stress; Propanolamines | 2008 |
Treatment of coronary spastic angina with a statin in addition to a calcium channel blocker: a pilot study.
Topics: Angina Pectoris, Variant; Calcium Channel Blockers; Cholesterol, HDL; Cholesterol, LDL; Coronary Vasospasm; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Pilot Projects; Pravastatin | 2008 |
Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis.
Topics: Acetaldehyde; Animals; Aorta; Atherosclerosis; Dihydropyridines; Epitopes; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Proteins; Rats; Rats, Sprague-Dawley | 2010 |
Malondialdehyde-derived epitopes in human skin result from acute exposure to solar UV and occur in nonmelanoma skin cancer tissue.
Topics: Cell Line; Cell Survival; Dihydropyridines; Epitopes; Gas Chromatography-Mass Spectrometry; Humans; Immunohistochemistry; In Vitro Techniques; Keratinocytes; Malondialdehyde; Oxidative Stress; Proteins; Skin; Tissue Array Analysis; Ultraviolet Rays | 2014 |
Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
Topics: Animals; Benzoates; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular Diseases; Deferasirox; Deferiprone; Deferoxamine; Dihydropyridines; Heart; Iron Chelating Agents; Iron Overload; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mitochondria; Nitrophenols; Organophosphorus Compounds; Pyridones; Thalassemia; Triazoles | 2016 |
Edaravone, a potent free radical scavenger and a calcium channel blocker attenuate isoproterenol induced myocardial infarction by suppressing oxidative stress, apoptotic signaling and ultrastructural damage.
Topics: Animals; Antipyrine; Apoptosis; C-Reactive Protein; Calcium Channel Blockers; Caspase 3; Dihydropyridines; Edaravone; Female; Free Radical Scavengers; Isoproterenol; Male; Malondialdehyde; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Rats, Wistar | 2016 |
Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
Topics: Aminophylline; Animals; Apoptosis; Atropine; Blood Pressure; Calcium Channel Blockers; Calcium Channels, T-Type; Deferiprone; Dihydropyridines; Drug Combinations; Heart; Heart Rate; Iron; Iron Chelating Agents; Iron Overload; Male; Malondialdehyde; Mice; Mitochondria; Myocardium; Nitroglycerin; Nitrophenols; Organelle Biogenesis; Organophosphorus Compounds; Oxidative Phosphorylation; Papaverine; Phenobarbital; Pyridones; Signal Transduction; Thalassemia | 2017 |
Prevention of infertility induced by ovarian ischemia reperfusion injury by benidipine in rats: Biochemical, gene expression, histopathological and immunohistochemical evaluation.
Topics: Animals; Apoptosis; Dihydropyridines; Female; Gene Expression; Glutathione; Infertility, Female; Interleukin-1beta; Malondialdehyde; Models, Animal; Ovary; Rats, Wistar; Reperfusion Injury; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2017 |
Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-β/SMAD-2-Dependent Signaling Pathway in Diabetic Rats.
Topics: Acetylcholinesterase; Animals; Brain; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Dihydropyridines; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Neuroprotective Agents; Nitrites; Nitrophenols; Organophosphorus Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2021 |
Effect of adenosine triphosphate, benidipine and their combinations on bevacizumab-induced kidney damage in rats.
Topics: Adenosine Triphosphate; Animals; Bevacizumab; Dihydropyridines; Kidney; Malondialdehyde; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2021 |